Neuropsicofarmacología - GIC 21/128
![Foto de Neuropsicofarmacología - GIC 21/128](/img/grupo.png)
![Foto de Instituto de Biomedicina y Biotecnología de Cantabria](/img/noimage_org.png)
Instituto de Biomedicina y Biotecnología de Cantabria
Santander, EspañaPublications in collaboration with researchers from Instituto de Biomedicina y Biotecnología de Cantabria (7)
2019
-
Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics
Translational Psychiatry, Vol. 9, Núm. 1
2018
-
Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders
Biochemical Pharmacology, Vol. 157, pp. 258-265
-
The endocannabinoid system in mental disorders: Evidence from human brain studies
Biochemical Pharmacology, Vol. 157, pp. 97-107
2017
-
Antipsychotic-induced Hdac2 transcription via NF-ΰ B leads to synaptic and cognitive side effects
Nature Neuroscience, Vol. 20, Núm. 9, pp. 1247-1259
2016
-
Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia
Science Signaling, Vol. 9, Núm. 410
2014
2008
-
Gene expression patterns in brain cortex of three different animal models of depression
Genes, Brain and Behavior, Vol. 7, Núm. 6, pp. 649-658